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Abstract
Background: Influenza A virus can infect a wide variety of animal species including humans, pigs, birds and other
species. Viral ribonucleoprotein (vRNP) was involved in genome replication, transcription and host adaptation.
Currently, firefly luciferase (Fluc) reporter system was used in vRNP functional assay. However, its limitation for the
testing by virus infection resulted in an increased need for rapid, sensitive, and biosafe techniques. Here, an
influenza A virus UTR-driven gene reporter for vRNP assay based on secreted Gaussia luciferase (Gluc) activity was
evaluated.
Results: By measuring Gluc levels in supernatants, reporter gene activity could be detected and quantitated after
either reconstitution of influenza A virus polymerase complex or viral infection of 293T and A549 cells, respectively.
As compared with Fluc reporter, Gluc-based reporter was heat-tolerant (65°C for 30 min) and produced 50-fold
higher bioluminescent activity at 24 h posttransfection. Signals generated by Gluc reporter gene could be detected
as early as 6 h post-infection and accumulated with time. Testing by viral infection, stronger signals were detected
by Gluc reporter at a MOI of 0.001 than that of 1 and the effects of PB2-627K/E or amantadine on influenza vRNP
activity were elucidated more effectively by the Gluc reporter system.
Conclusions: This approach provided a rapid, sensitive, and biosafe assay of influenza vRNP function, particularly
for the highly pathogenic avian influenza viruses.
Background
Bioluminescence reporters such as firefly, click-beetle,
Renilla, Gaussia, Cypridina luciferases, and calcium-
activated photoproteins are widely used in molecular
biology. Of them, the firefly luciferase (Fluc) from the
North American firefly, first cloned and sequenced by
Wet et al. in 1985, is the most commonly used [1].
Gaussia luciferase (Gluc), naturally secreted from the
marine copepod, was reported by Tannous in 2005 and
found to be ~2000-fold more sensitive than either the
Fluc or Renilla reniformis luciferases [2]. Expression
levels in growth medium are readily quantifiable by
addition of coelenterazine and luminometry [2]. To
date, Gluc has been used for the detection and quantifi-
cation of protein interactions [3], siRNA [4], miRNA [5],
promoter activity [6], and viral infection and replication
[7]. Furthermore, the Gluc reporter system has also
been used in live animal studies [8], and use of a biolu-
minescence detector [9] facilitated imaging of tumor cell
trafficking and proliferation in vivo.
Influenza viruses are members of the family Orthomyxo-
viridae and are composed of three types: A, B, and C.
They possess a single-stranded, negative-sense RNA gen-
ome consisting of eight (influenza A & B) or seven (influ-
enza C) segments. Formation of a viral polymerase
complex consisting of PB2, PB1, and PA proteins together
with NP is required for successful replication [10]. Twelve
conserved nucleotides at the 3’,a n d1 3a tt h e5 ’ UTR
regions of vRNA are essential for polymerase recognition
and binding for type A virus. Lutz and co-workers [11]
introduced influenza A virus-inducible reporter gene
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A/WSN/33 NP segment) into a Fluc reporter system to
detect and quantify RNP activity. This system has been
used to study influenza virus RNP activity by transfection
or viral infection of susceptible cells.
Co-transfecting cells with four plasmids encoding PB2,
PB1, PA, and NP and a reporter gene avoids the genera-
tion of infectious virons and a BSL-3 facility for handling
t h eh i g h l yp a t h o g e n i ca v i a ni n f l u e n z av i r u s .M o r e o v e r ,
RNP activity testing by viral infection of susceptible cells
could be mandated when RNP expression plasmids are
unavailable. However, a relatively weaker regulation
mediated by virus infection directly than that by poly-
merase complex transfection limited the application of
Fluc system. Therefore, it is necessary to develop a rapid,
sensitive, quantitative, and safe assay for determining
influenza virus polymerase activity. Here, we report a
secreted influenza viral UTR-driven Gaussia luciferase
(Gluc) reporter system for RNPs function assay.
Materials and methods
Plasmids
Plasmid pAAV-Gluc-Fluc (provided by Dr. Xiaobing
Wu) was used as the template for Gluc reporter gene
amplification. The primers used are listed in Table 1.
After purification using the QIAquick Gel Extraction Kit
(Qiagen, Valencia, CA, USA), PCR products were cloned
into vectors containing the RNA polymerase I promoter
and terminator using the In-Fusion(tm) Advantage PCR
Cloning Kit (Clontech, Mountain View, CA, USA)
according to the manufacturer’s instructions. Plasmid of
polI-Gluc was sequenced to ensure the absence of
unwanted nucleotide changes.
All eight gene segments of influenza viruses A/Quail/
HK/G1/97 (H9N2, G1) and BH Gs/QH/1/2005 (H5N1,
QH) were amplified by RT-PCR and cloned into a mod-
ified version of the bidirectional expression plasmid
pCQI, derived from pHW2K. A mutation resulting in a
change of lysine (K) to glutamic acid (E) was introduced
into the PB2 gene of QH strain; this virus was named
QH (PB2-627E). The reporter plasmid pYH-Fluc was
kindly provided by Erich Hoffmann.
Cells
Human embryonic kidney (293T) and human type II
alveolar epithelial (A549) cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM; Invitro-
gen, Carlsbad, CA, USA) supplemented with 10% fetal
bovine serum (FBS; Invitrogen), glutamine (2 mM; Invi-
trogen), HEPES (10 mM; Invitrogen), penicillin (100
units/ml), and streptomycin (100 μg/ml; Invitrogen) and
incubated in a humidified atmosphere of 5% CO2 at 37°C.
Virus preparation and titration
Recombinant viruses G1, QH (PB2-627K), and QH
(PB2-627E) were maintained as reported previously
[12,13]. Viral titrations were determined using A549
cells, and the tissue culture infectious dose affecting
50% of the cells (TCID50) was calculated using the
Reed-Muench formula [14]. All experiments involving
live H5N1 viruses were performed in a BSL-3 facility.
Transfection and virus infection for RNP activity
measurement
Reporter plasmids pYH-Fluc (0.1 μg) and polI-Gluc
(0.1 μg) were co-transfected with expression plasmids
encoding PB2, PB1, PA, and NP into 293T cells (1 × 10
5
and 5 × 10
4 /well in 24- and 96-well plates, respectively)
using the PolyFect (Qiagen) reagent according to the
manufacturer’s instructions. Mock transfections were
performed with either pYH-Fluc or polI-Gluc alone, as
appropriate. For assay RNP activity by virus infection,
A549 cells (1 × 10
5 /well) were transfected with polI-
Gluc, again using the PolyFect reagent. After 6 h incuba-
tion at 37°C, cells were washed with phosphate buffered
saline (PBS), and then the virus was introduced at a mul-
tiplicity of infection (m.o.i.) of either 1 or 0.001. Mock
infections were performed using sterile culture medium.
Inhibition of influenza A virus infection by amanta-
dine was assessed by incubating polI-Gluc- or pYH-
Fluc-transfected A549 cells with 0.21 μMa m a n t a d i n e
for 30 min prior to the addition of the virus. After incu-
bation for 1 h at 37°C, supernatant was decanted, and
cells were washed with PBS and then incubated at 37°C
in DMEM containing amantadine.
Luciferase assay
Gluc activity in supernatants (cell-free media; 20 μl) was
analyzed using a Gluc assay Kit (New England Biolabs,
Beverly, MA, USA). Transfected or infected cells were
gently washed twice in PBS, followed by the addition of
200 μl 1× passive lysis buffer (Promega, Madison, WI,
Table 1 Primer sequences used in the construction of the viral UTR-driven Gluc reporter
Gluc-F 5’-GGCCGCCGGGTTATTAGTAGAAACAAGGGTATTTTTCTTTAGTCACCACCGGCCCCCTTGATC -3’
Gluc-R1 5’-CCTCCGAAGTTGGGGAGCAAAAGCAGGGTAGATAATCACTCACAGAGTGACATCGAAAAT-3 ‘
Gluc-R2 5’-CACAGAGTGACATCGAAAATGGGAGTCAAAGTTCTGTTTGCCCT-3’
Bold portions correspond to sequences within the coding region of the reporter gene. The remaining 5’ sequences (15 nt, italics) are necessary for In-Fusion
cloning into the RNA polymerase I vector polI-sapI. Underlined parts correspond to the untranslated regions of the A/WSN/33 NP segment. Two reverse primers
(R1, R2) were designed to ensure PCR efficiency.
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5 min at 10,000 rpm, and Fluc activity in supernatants
(cell lysates; 20 μl) was measured by addition of
D-luciferin (100 μl; Promega) and by measurement of
fluorescence intensity for 10 s using a Modulus Lumin-
ometer machine (Promega).
Statistical analysis
All determinations were performed in triplicate and
repeated three times. Data are expressed as means ±
SEM. Statistical significance was determined using non-
parametric tests and the GraphPad Prism 5 software
package (GraphPad Software). A P-value < 0.05 was
deemed to indicate statistical significance.
Results
Efficacy of the Gluc reporter system
A virus-inducible Fluc reporter gene system has been
developed and used for quantification of influenza virus
polymerase activity [11]. To assess the potential of Gaussia
protein as a reporter, we constructed artificial RNA seg-
ments encoding the Gaussia protein under the control of
the UTRs of influenza A/WSN/33 NP segment. These
artificial RNA segments were cloned into the RNA poly-
merase I promoter/terminator cassette to produce RNA
transcripts containing no additional nucleotide sequences
or modifications at either the 5’ or 3’ end. The vector polI-
Gluc and plasmids carrying the PB1, PB2, PA, and NP seg-
ments of influenza virus G1 (H9N2) were co-transfected
into 293T cells, and RNP activity was determined. Around
a 600-fold higher luciferase activity was detected in super-
natants at 18 h post-transfection as compared with that in
mock-transfected cells (Figure 1A). Furthermore, Gluc sig-
nal accumulated with time. In contrast, the Fluc reporter
gene signal peaked at 24 h post-transfection and subse-
quently remained at this level (Figure 1B).
The efficacy of the Gluc reporter system in assessing
viral infection was examined. Little luciferase protein
expression was detected from the construct in the absence
of an authentic influenza A virus polymerase, similar to
luciferase signals of non-transfected cells (data not
shown). FluA polI-Gluc-transfected A549 cells were
infected with influenza virus G1 (MOI of 1), and superna-
tants were harvested for luciferase analysis at 0, 3, 6, 9, 12,
and 24 h post-infection (p.i.; Figure 1C). Signal was
detected as early as 6 h p.i. At 24 h p.i., luciferase activity
in G1-infected A549 cell supernatants was ~20-fold higher
than that in mock-treated cells (Figure 1C). Thus, the
Gluc system was capable of quantifying RNP activity and
performed similar to the Fluc reporter system.
Sensitivity of Gluc reporter system
Gluc is > 1000-fold more sensitive than the American
firefly or sea pansy Renilla reniformis luciferases [2]. To
compare sensitivities of the Gluc versus Fluc reporter
systems, we transfected 293T cells with six plasmids: the
vectors polI-Gluc and pYH-Fluc and plasmids encoding
the G1 (H9N2) viral RNP. Supernatants of Gluc-trans-
fected cells showed a 50-fold higher bioluminescent
activity compared with Fluc-transfected cells at 24 h
posttransfection (Figure 1B), again indicating the sensi-
tivity of the Gluc-based system.
Thermostability of Gluc reporter system
Gluc is stable in culture medium (half-life around 6 d)
[7], and therefore samples can be stored at 4°C for sev-
eral days without any significant change in Gluc activity.
Gluc is also heat stable at 65°C [15]. Influenza viruses
are not heat-resistant and can be inactivated at 56°C for
30 min or 100°C for 1 min[16,17], and at 65°C for 30
Figure 1 RNP assaying by Fluc and Gluc systems after
reconstitution of influenza A virus polymerase complex.( A)
Polymerase activity assayed by a viral UTR-driven Gluc reporter
gene. (B) Detection and quantification of RNP activity by the Gluc
or Fluc reporter systems after transfection. 293T cells were
transfected with plasmids encoding the PB2, PB1, PA, and NP genes
of A/Quail/HK/G1/97 (H9N2) plus reporter plasmids polI-Gluc or
pYH-Fluc. Supernatants (cell-free culture medium) and cell lysates
were assayed for luciferase activity using appropriate substrates by a
luminometer. (C) Kinetics of G1 RNP activity assayed using the Gluc
reporter system after virus infection. A549 cells were transfected
with plasmid polI-Gluc and infected at 6 h post-transfection with
influenza virus G1 at a MOI of 1. Luciferase activity in supernatants
was assayed at 0, 3, 6, 9, 12, and 24 h post-G1 (H9N2) infection and
expressed as RLU per well. Data are expressed as standard errors of
the mean (SEM) from three independent experiments performed in
triplicate.
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pared Fluc and Gluc activities after heat treatment. Vec-
tors polI-Gluc and pYH-Fluc were introduced together
by both transfection and influenza virus infection and
supernatants were harvested for Gluc assay and cells
lysates for Fluc analysis. All samples were treated at 65°
C for 10 or 30 min, and then Gluc and Fluc activities
were determined. Gluc-transfected supernatants main-
tained > 90% activity after treatment at 65°C for 10 min
and > 70.0% after 65°C for 30 min. In contrast, Fluc
activity decreased to < 10% after heating for 10 min and
was almost totally absent after 30 min (Figure 2A). Simi-
lar results were found by viral infection (Figure 2B).
Determination of optimum infectious dose
Fluc reporter quantitation was linear in 293T cell
infected with influenza virus at a MOI of 0.001-0.1 [11].
To elucidate the optimal infectious dose of the Gluc sys-
tem, we transfected A549 cells (1 × 10
5) with both pYH-
Fluc and polI-Gluc, and infected cells with influenza A
virus G1 at a MOI of 1 or 0.001, respectively. Fluc and
Gluc activity was assayed following 24 h incubation at
37°C (Figure 3). Gluc (Figure 3B-D), but not Fluc (Fig-
ure 3A) activity was significantly different at a MOI of
0.001 as compared with a MOI of 1. Thus, our findings
suggested that a MOI of 0.001 was better than that of 1
for the Gluc reporter assay under these conditions.
Verification of PB2-K627E-induced RNP activity
A single residue at position 627 in the PB2 subunit of
the influenza polymerase (PB2-627) has been reported
to be critical for polymerase activity in a species-specific
fashion [19-23]. Most human influenza viruses possess a
lysine at this position (PB2-627K), and most avian
viruses possess glutamic acid (PB2-627E). PB2-627K is
correlated with enhanced polymerase activity [19] and
the high virulence [24] of H5N1 viruses in mice. PB2-
627E attenuates viral replication efficiency and patho-
genicity in mammals [25]. We verified these findings
using the Gluc reporter system by both transfection
with viral RNPs (Figure 4) and infection with QH (PB2-
627K) and QH (PB2-627E) viruses (Figure 3C & 3D).
Signal was stronger in the Gluc than in the Fluc repor-
ter system. A significant difference between PB2-627K
and PB2-627E, which was consistent with other reports,
was detected using the Gluc reporter system at a MOI
of 0.001, but not at a MOI of 1 (Figure 3C & 3D).
Furthermore, this effect was blocked by addition of
amantadine, an influenza virus entry inhibitor (Figure
3B-D; P < 0.05).
Discussion
The influenza virus RNA-dependent RNA polymerase
complex subunits (PB1, PB2, and PA) and NP catalyze
both genome replication and transcription. This com-
plex is also involved in influenza virus host adaptation
[26]. In particular, a mutation in residue 627 of the PB2
segment (glutamic acid to lysine) is necessary for avian
and swine influenza viruses to infect humans [27]. The
H5N1 reassortant virus that contains a PB2 segment
from human seasonal H3N2 is more virulent than the
parental H5N1 strain in a mouse model [28]. Recently, a
number of laboratories use Fluc reporter system to
detect RNP activity. As for the limitations of Fluc sys-
tem for RNP assay by virus infection, a system for deter-
mining influenza virus polymerase activity which would
be more sensitive, easier to handle and allow more
widespread use is essential.
Here, we first introduced Gaussia luciferase into a
viral UTR-driven reporter system. Gaussia luciferase is a
monomeric protein from the copepod marine organism
Gaussia princeps. The small size of this gene (555 bp),
together with its relative lack of toxicity, makes it
Figure 2 Heat-sensitivity of Gluc and Fluc.( A) RNP activity in
polI-Gluc- and pYH-Fluc-transfected 293T cells after heat-treatment.
293T cells were transfected with plasmids encoding the PB2, PB1,
PA, and NP segments of influenza G1 (H9N2) plus reporter plasmids
polI-Gluc and pYH-Fluc. Supernatants and corresponding cell lysates
were heated at 65°C for 10 or 30 min, and then Gluc and Fluc
activities were assayed. (B) RNP activity in G1-infected A549 cells
after heat treatment. Polymerase activity assays were performed in
A549 cells transfected with vRNA Gaussia and firefly reporter
plasmids and then infected with H9N2 at 6 h post-transfection.
Supernatants and corresponding cell lysates were harvested for
assay of Gluc and Fluc activity at appropriate times. Data are
expressed as standard errors of the mean (SEM) from three
independent experiments performed in triplicate.
Zhu et al. Virology Journal 2011, 8:29
http://www.virologyj.com/content/8/1/29
Page 4 of 7suitable for vector construction and application. More-
over, Gaussia luciferase is naturally secreted and has a
broad pH optimum as compared with other luciferases,
with peak activity at pH 7.7 [29]. The Gluc reporter
gene was activated and expressed via reconstitution of
influenza A virus polymerase complex by either trans-
fection or direct viral infection (Figure 1). The Gluc
reporter produced a strong signal that accumulated with
time (600- and 20-fold higher than controls in trans-
fected and virus-infected supernatants, respectively; Fig-
ure 1), while Fluc signals saturated at 24 h p.i. with
similar observation reported by Sun et al [30]. Further-
more, the Gluc reporter gene system was both much
more sensitive and more heat stable than the Fluc sys-
tem (Figs. 1B & 2B).
Fluc was activated by G1 (H9N2) infection, but did
not differ between one (MOI of 1) and multiple infec-
tion cycles (MOI of 0.001). Additionally, no significant
effect of amantadine on G1 vRNP activity was found at
neither MOI of 1 nor 0.001 (Figure 3A). Notably,
stronger signal was detected at MOI of 0.001 than that
of 1 for the Gluc reporter assay. Furthermore, signal
produced by the Gluc system at MOI of 1 or 0.001
could be modified by addition of amantadine, an influ-
enza virus ion blocker (Figure 3B-D), implying the
powerful potency of Gluc system for RNP assay and the
screening of antiviral compounds.
Similarly, significant differences between induction
by PB2-627K and PB2-627E were detected by both the
Gluc and Fluc reporter systems after reconstitution of
viral RNPs by transfection (Figure 4), as well as after
multiple infection cycles using the Gluc reporter sys-
tem (Figure 3C-D). Our data suggest that multiple
infection cycles might be better for the Gluc reporter
system, which may be explained by the efficiency of
infection at a low concentration of virus and the resul-
tant amplification of the Gluc signal, showing that the
effects of PB2-627K/E or amantadine on influenza
vRNP activity were elucidated more effectively by the
Gluc reporter system.
Figure 3 The effect of virus dose and addition of antivirals on RNP activity. A549 cells were transfected with plasmids pYH-Fluc (A) or polI-
Gluc (B, C, and D) and incubated with or without amantadine (0.21 μM) for 30 min at 6 h post-transfection. Infections were performed with
recombinant viruses G1 (A, B), QH (PB2-627K) (C), or QH (PB2-627E) (D) at a MOI of 1 and 0.001. At 24 h p.i., cells were lysed, and Fluc (A) and
Gluc activity (B-D) were assayed. Data are expressed as standard errors of the mean (SEM) from three independent experiments performed in
triplicate. A, amantadine; * P < 0.05.
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Generally, Gluc system constructed here provided an
alternative method for evaluating influenza virus poly-
merase activities, and showed much more advantages
than traditional Fluc system. Firstly, Gluc luciferase was
naturally secreted from cells into culture medium and
could be detected readily. Secondly, much stronger sig-
nal intensity was generated by Gluc system. Finally,
besides of its heat-resistance, Gluc reporter system
works better during viral infection, which is suitable for
RNP assay by direct virus infection and avoids con-
structing RNP plasmids. The reporter system based on
secreted Gaussia luciferase activity for assaying influenza
virus RNP functionality is sensitive, easier-detectable,
and thermo-stable and is a potential tool for influenza
virology study, especially for highly pathogenic avian
influenza virus.
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